Topics

Human genetics is reshaping drug discovery by revealing reliable targets, improving success rates, and reducing costly clinical failures in the development of safer, more effective treatments.

Alzheimer's candidate KCL-286 repairs neuronal DNA damage, cuts neuroinflammation in mice. Safe for humans, this amyloid alternative targets multiple pathways.

InnoCare's TYK2 inhibitor soficitinib hits vitiligo Phase 2 endpoint, advancing to Phase 3. Competitive autoimmune skin disorder trial shows strong F-VASI improvement.

AI-driven drug discovery is transforming biotechnology as Big Tech acquires biotech startups, redefining pharmaceutical innovation and the future of AI-powered healthcare.

AI-driven drug discovery fueled 26 novel FDA therapy approvals in early 2026, delivering breakthrough cancer treatments and first-ever options for rare neurological disorders.

Researchers developed six novel drugs aimed at killing resistant bacteria strains linked to 5 million deaths a year

AI creates effective drug candidates by analyzing only the target protein's structure, potentially reducing costs and time in developing treatments for diseases like cancer.

Also helps drug development

Combining automated experiments with machine learning greatly speeds up the complex drug-design process

Improved brain and vascular protection in rats after ischemic stroke